Stocks and Investing Stocks and Investing
Thu, April 28, 2022

Jonathan Yong Downgraded (TDOC) to Hold and Decreased Target to $35 on, Apr 28th, 2022


Published on 2024-10-27 20:42:05 - WOPRAI, Jonathan Yong
  Print publication without navigation


Jonathan Yong of Credit Suisse, Downgraded "Teladoc Health, Inc." (TDOC) to Hold and Decreased Target from $114 to $35 on, Apr 28th, 2022.

Jonathan has made no other calls on TDOC in the last 4 months.



There are 11 other peers that have a rating on TDOC. Out of the 11 peers that are also analyzing TDOC, 4 agree with Jonathan's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Kevin Caliendo of "UBS" Maintained at Hold with Decreased Target to $72 on, Tuesday, March 8th, 2022
  • David Grossman of "Stifel" Maintained at Hold with Decreased Target to $74 on, Wednesday, February 23rd, 2022
  • Steve Valiquette of "Barclays" Maintained at Hold with Decreased Target to $77 on, Wednesday, February 23rd, 2022
  • Glen Santangelo of "Jefferies" Maintained at Hold with Decreased Target to $82 on, Monday, February 7th, 2022


These are the ratings of the 7 analyists that currently disagree with Jonathan


  • Jessica Tassan of "Piper Sandler" Maintained at Buy with Decreased Target to $104 on, Tuesday, March 8th, 2022
  • John Eade of "Argus Research" Upgraded from Hold to Strong Buy and Held Target at $95 on, Thursday, March 3rd, 2022
  • Jailendra Singh of "Credit Suisse" Maintained at Buy with Decreased Target to $114 on, Friday, February 25th, 2022
  • Donald Hooker of "Keybanc" Maintained at Buy with Decreased Target to $100 on, Wednesday, February 23rd, 2022
  • Lisa Gill of "JP Morgan" Maintained at Buy with Decreased Target to $125 on, Wednesday, February 23rd, 2022
  • Michael Wiederhorn of "Oppenheimer" Maintained at Buy with Decreased Target to $130 on, Wednesday, February 23rd, 2022
  • Cindy Motz of "Goldman Sachs" Initiated at Strong Buy and Held Target at $121 on, Friday, February 11th, 2022
Contributing Sources